Five-Year Study on Aveed’s Impact on PSA Levels in American Males with Hypogonadism
Reading Time: < 1 minuteIntroduction Prostate health remains a critical concern among American males, with prostate-specific antigen (PSA) levels serving as a primary indicator of prostate function and potential disease. Aveed, a testosterone replacement therapy developed by Endo Pharmaceuticals, has been increasingly utilized for treating hypogonadism. However, its long-term effects on prostate health, particularly in relation to PSA levels, warrant thorough investigation. This article... Read more »